Research summary ·
Argentine consensus on the clinical utility of breath tests and small intestinal bacterial overgrowth management in patients with disorders of gut-brain interaction.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This is a joint statement from a group of experts in Argentina. It covers breath tests in people with gut-brain disorders. The focus was on too many germs in the gut. Health workers with skill in these tests met in person. They talked over a list of items and voted on each.
What they found
The group voted on 32 items. Of these, 13 got strong agreement. Another 10 got some agreement. The group felt the breath test is safe and useful for these people. They also saw it as useful in IBS with constipation.
What it means for patients
The group says H2 and CH4 gas should be tested at the same time. A flat line on the test may point to the gut making too much sulfide. High H2 at the start may mean the diet before the test was not kept. A CH4 level of 10 ppm or more may signal methane-making germ overgrowth. For germ overgrowth, they say doctors should use an antibiotic the gut does not absorb. Rifaximin is given as one example of this kind of drug. They also stress noting symptoms while the test is done.
Why it is not certain yet
These points come from expert views, not from a new trial. The meeting took place in Argentina only. Not all items got agreement, and some got only partial agreement. The abstract does not give the data behind each vote. A joint statement can only be as strong as the views behind it.
Source
Argentine consensus on the clinical utility of breath tests and small intestinal bacterial overgrowth management in patients with disorders of gut-brain interaction.
PubMed · PMID 42816255We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Irritable bowel syndrome publications